JAK2 and myeloproliferative disorder: In MPN with Calreticulin mutations (CALRmut)—the most common driver mutation in JAK2 wildtype (JAK2wt) MPN, occurring in about 25% of ET and PMF patients (74)—a frameshift mutation leads to an altered c-terminus of the protein.